SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 96 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 2,186,520 | $38,526,000 | 10.61% |
| Cormorant Asset Management, LP | 1,945,334 | $34,277,000 | 4.56% |
| Aisling Capital LLC | 1,703,855 | $30,022,000 | 4.47% |
| Wildcat Capital Management, LLC | 736,012 | $12,968,000 | 4.44% |
| ACUTA CAPITAL PARTNERS, LLC | 212,402 | $3,743,000 | 2.31% |
| Healthcare Value Capital, LLC | 50,000 | $881,000 | 0.92% |
| EAM Investors, LLC | 249,028 | $4,388,000 | 0.51% |
| TFS CAPITAL LLC | 150,812 | $2,657,000 | 0.26% |
| GAGNON SECURITIES LLC | 11,001 | $194,000 | 0.08% |
| Granite Investment Partners, LLC | 43,861 | $772,000 | 0.07% |